Selected research
Industry Growth & Trends
Global Granisetron Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Granisetron market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Granisetron market include Kyowa Kirin, Teva, Sandoz, Mylan, Fresenius Kabi, Wockhardt, Taro Pharmaceutical, Natco Pharma and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Granisetron market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Granisetron market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Granisetron market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Granisetron.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Granisetron market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Granisetron Market by Company
Kyowa Kirin
Teva
Sandoz
Mylan
Fresenius Kabi
Wockhardt
Taro Pharmaceutical
Natco Pharma
Hikma Pharmaceuticals
Heron Therapeutics
Dr.Reddy's
Cipla
Bluepharma
Aurobindo
APOTEX
Akorn
Granisetron Segment by Type
Injection
Transdermal system
Oral
Granisetron Segment by Application
Chemotherapy
Post operative
Granisetron Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granisetron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Granisetron and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granisetron.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Granisetron companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Transdermal system
- Oral
Applications
- Chemotherapy
- Post operative
Companies covered
- Kyowa Kirin
- Teva
- Sandoz
- Mylan
- Fresenius Kabi
- Wockhardt
- Taro Pharmaceutical
- Natco Pharma
- Hikma Pharmaceuticals
- Heron Therapeutics
- Dr.Reddy's
- Cipla
- Bluepharma
- Aurobindo
- APOTEX
- Akorn
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Granisetron Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Granisetron Market Size by Region (2021-2032)
- 1.4.1 Global Granisetron Market Size by Region (2021-2026)
- 1.4.2 Global Granisetron Market Size by Region (2027-2032)
- 1.5 Key Regions Granisetron Market Size (2021-2032)
- 1.5.1 North America Granisetron Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Granisetron Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Granisetron Market Size Growth Rate (2021-2032)
- 1.5.4 South America Granisetron Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Granisetron Market Size Growth Rate (2021-2032)
2 Granisetron Market by Type
- 2.1 Type Introduction
- 2.1.1 Injection
- 2.1.2 Transdermal system
- 2.1.3 Oral
- 2.2 Global Granisetron Market Size by Type
- 2.2.1 Global Granisetron Market Size Overview by Type (2021-2032)
- 2.2.2 Global Granisetron Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Granisetron Market Size Forecasted by Type (2027-2032)
- 2.3 Global Granisetron Market Size by Regions
- 2.3.1 North America Granisetron Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Granisetron Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Granisetron Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Granisetron Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Granisetron Market Size Breakdown by Type (2021-2026)
3 Granisetron Market by Application
- 3.1 Type Introduction
- 3.1.1 Chemotherapy
- 3.1.2 Post operative
- 3.2 Global Granisetron Market Size by Application
- 3.2.1 Global Granisetron Market Size Overview by Application (2021-2032)
- 3.2.2 Global Granisetron Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Granisetron Market Size Forecasted by Application (2027-2032)
- 3.3 Global Granisetron Market Size by Regions
- 3.3.1 North America Granisetron Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Granisetron Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Granisetron Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Granisetron Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Granisetron Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Granisetron Industry Trends
- 4.2 Granisetron Industry Drivers
- 4.3 Granisetron Industry Opportunities and Challenges
- 4.4 Granisetron Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Granisetron Revenue (2021-2026)
- 5.2 Global Granisetron Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Granisetron Key Company Headquarters & Area Served
- 5.4 Global Granisetron Company, Product Type & Application
- 5.5 Global Granisetron Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Granisetron Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Granisetron Players Market Share by Revenue in 2025
- 5.6.3 2025 Granisetron Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Kyowa Kirin
- 6.1.1 Kyowa Kirin Company Information
- 6.1.2 Kyowa Kirin Business Overview
- 6.1.3 Kyowa Kirin Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Kyowa Kirin Granisetron Product Portfolio
- 6.1.5 Kyowa Kirin Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Teva Granisetron Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Sandoz
- 6.3.1 Sandoz Company Information
- 6.3.2 Sandoz Business Overview
- 6.3.3 Sandoz Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sandoz Granisetron Product Portfolio
- 6.3.5 Sandoz Recent Developments
- 6.4 Mylan
- 6.4.1 Mylan Company Information
- 6.4.2 Mylan Business Overview
- 6.4.3 Mylan Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Mylan Granisetron Product Portfolio
- 6.4.5 Mylan Recent Developments
- 6.5 Fresenius Kabi
- 6.5.1 Fresenius Kabi Company Information
- 6.5.2 Fresenius Kabi Business Overview
- 6.5.3 Fresenius Kabi Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Fresenius Kabi Granisetron Product Portfolio
- 6.5.5 Fresenius Kabi Recent Developments
- 6.6 Wockhardt
- 6.6.1 Wockhardt Company Information
- 6.6.2 Wockhardt Business Overview
- 6.6.3 Wockhardt Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Wockhardt Granisetron Product Portfolio
- 6.6.5 Wockhardt Recent Developments
- 6.7 Taro Pharmaceutical
- 6.7.1 Taro Pharmaceutical Company Information
- 6.7.2 Taro Pharmaceutical Business Overview
- 6.7.3 Taro Pharmaceutical Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Taro Pharmaceutical Granisetron Product Portfolio
- 6.7.5 Taro Pharmaceutical Recent Developments
- 6.8 Natco Pharma
- 6.8.1 Natco Pharma Company Information
- 6.8.2 Natco Pharma Business Overview
- 6.8.3 Natco Pharma Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Natco Pharma Granisetron Product Portfolio
- 6.8.5 Natco Pharma Recent Developments
- 6.9 Hikma Pharmaceuticals
- 6.9.1 Hikma Pharmaceuticals Company Information
- 6.9.2 Hikma Pharmaceuticals Business Overview
- 6.9.3 Hikma Pharmaceuticals Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Hikma Pharmaceuticals Granisetron Product Portfolio
- 6.9.5 Hikma Pharmaceuticals Recent Developments
- 6.10 Heron Therapeutics
- 6.10.1 Heron Therapeutics Company Information
- 6.10.2 Heron Therapeutics Business Overview
- 6.10.3 Heron Therapeutics Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Heron Therapeutics Granisetron Product Portfolio
- 6.10.5 Heron Therapeutics Recent Developments
- 6.11 Dr.Reddy's
- 6.11.1 Dr.Reddy's Company Information
- 6.11.2 Dr.Reddy's Business Overview
- 6.11.3 Dr.Reddy's Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Dr.Reddy's Granisetron Product Portfolio
- 6.11.5 Dr.Reddy's Recent Developments
- 6.12 Cipla
- 6.12.1 Cipla Company Information
- 6.12.2 Cipla Business Overview
- 6.12.3 Cipla Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Cipla Granisetron Product Portfolio
- 6.12.5 Cipla Recent Developments
- 6.13 Bluepharma
- 6.13.1 Bluepharma Company Information
- 6.13.2 Bluepharma Business Overview
- 6.13.3 Bluepharma Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Bluepharma Granisetron Product Portfolio
- 6.13.5 Bluepharma Recent Developments
- 6.14 Aurobindo
- 6.14.1 Aurobindo Company Information
- 6.14.2 Aurobindo Business Overview
- 6.14.3 Aurobindo Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Aurobindo Granisetron Product Portfolio
- 6.14.5 Aurobindo Recent Developments
- 6.15 APOTEX
- 6.15.1 APOTEX Company Information
- 6.15.2 APOTEX Business Overview
- 6.15.3 APOTEX Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 APOTEX Granisetron Product Portfolio
- 6.15.5 APOTEX Recent Developments
- 6.16 Akorn
- 6.16.1 Akorn Company Information
- 6.16.2 Akorn Business Overview
- 6.16.3 Akorn Granisetron Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Akorn Granisetron Product Portfolio
- 6.16.5 Akorn Recent Developments
7 North America
- 7.1 North America Granisetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Granisetron Market Size by Country (2021-2026)
- 7.3 North America Granisetron Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Granisetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Granisetron Market Size by Country (2021-2026)
- 8.3 Europe Granisetron Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Granisetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Granisetron Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Granisetron Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Granisetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Granisetron Market Size by Country (2021-2026)
- 10.3 South America Granisetron Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Granisetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Granisetron Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Granisetron Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst